Use of GMI‐1271, an E‐selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis
Abstract Background There is an unmet need for antithrombotic treatments for venous thromboembolic disease that do not increase bleeding risk. Selectins are cell adhesion molecules that augment thrombosis by activating immune cells to initiate the coagulation cascade. GMI‐1271, a potent small‐molecu...
Main Authors: | Sumana Devata, Dana E. Angelini, Susan Blackburn, Angela Hawley, Daniel D. Myers, Jordan K. Schaefer, Martina Hemmer, John L. Magnani, Helen M. Thackray, Thomas W. Wakefield, Suman L. Sood |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12279 |
Similar Items
-
Systematic Review and Meta-Analysis of the Effect of Statins on Circulating E-Selectin, L-Selectin, and P-Selectin
by: Angelo Zinellu, et al.
Published: (2021-11-01) -
Targeting E-selectin to Tackle Cancer Using Uproleselan
by: Barbara Muz, et al.
Published: (2021-01-01) -
Lung-Derived Selectins Enhance Metastatic Behavior of Triple Negative Breast Cancer Cells
by: Sami U. Khan, et al.
Published: (2021-10-01) -
Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)
by: Sara El-Sayed Abd El-Ghani, et al.
Published: (2022-12-01) -
SELP Asp603Asn and severe thrombosis in COVID-19 males
by: Chiara Fallerini, et al.
Published: (2021-08-01)